Verona Pharma News

Verona Pharma Analyst Ratings

BenzingaSep 17 11:38 ET

H.C. Wainwright Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsSep 17 10:31 ET

Buy Rating Affirmed for Verona Pharma Amid Strategic Partnership and Market Potential for Novel COPD Treatment

TipRanksSep 17 09:49 ET

H.C. Wainwright Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsSep 11 08:33 ET

Verona Pharma Price Target Maintained With a $36.00/Share by HC Wainwright & Co.

Dow JonesSep 11 07:46 ET

Verona Pharma Analyst Ratings

BenzingaSep 11 07:37 ET

Truist Financial Maintains Verona Pharma(VRNA.US) With Buy Rating

Moomoo NewsSep 9 07:31 ET

Verona Pharma (VRNA) Receives a Buy From Truist Financial

TipRanksSep 9 07:19 ET

Piper Sandler Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsAug 22 07:33 ET

Piper Sandler Sticks to Its Buy Rating for Verona Pharma (VRNA)

TipRanksAug 22 06:47 ET

CCORF Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $37

Moomoo NewsAug 14 07:34 ET

Piper Sandler Maintains Verona Pharma(VRNA.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsAug 14 07:31 ET

Buy Rating Affirmed for Verona Pharma: Breakthrough COPD Treatment and Strategic Market Positioning

TipRanksAug 14 07:24 ET

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Verona Pharma (VRNA) and Aveanna Healthcare Holdings (AVAH)

TipRanksAug 9 08:35 ET

Optimistic Buy Rating for Verona Pharma Amidst Strong Ohtuvayre Launch and Expanding Clinical Trials

TipRanksAug 9 08:03 ET

Verona Pharma Analyst Ratings

BenzingaJul 22 08:37 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Astellas Pharma (OtherALPMF) and Verona Pharma (VRNA)

TipRanksJul 22 08:24 ET

Verona Pharma Analyst Ratings

BenzingaJul 1 07:03 ET

Verona Pharma Analyst Ratings

BenzingaJun 27 06:24 ET

Verona Pharma Analyst Ratings

BenzingaMay 15 06:13 ET